Neuphoria Therapeutics Inc. (NEUP) at a glance

Neuphoria Therapeutics Inc. (NEUP) is a micro-cap Healthcare company. It trades at $3.76, with a P/E of 1.1 and a 0% profit margin. It does not pay a dividend. Vestovix scores it 60/100 overall. Its strongest dimension is Value (99/100) and its weakest is Momentum (14/100).

Price
$3.76
Market cap
$20.3M
P/E ratio
1.1
Dividend yield
None
Beta
n/a
52-week range
$3.19 to $21.40
Vestovix Score60/ 100How this works
Value
99
Growth
50
Income
40
Safety
66
Momentum
14

Other Healthcare stocks

See all